FDC Share Price Today | Stock Price & FDC Share Screener

FDC Pharmaceuticals & Biotechnology
Live Share Price NSE
₹373.90
▼ -2.00 (-0.53%)
2026-11-18 00:00:00
Live Share Price BSE
₹373.90
▼ -2.95 (-0.78%)
2026-11-18 00:00:00

As of November 18, 2026, the live FDC share price (NSE: FDC) is ₹373.90 on NSE and ₹373.90 on BSE, down 0.53% from the previous close, with shares trading between ₹368.50 and ₹378.00 in today's trading session, and a 52-week range of ₹321.10–₹434.25. Track FDC networth to gauge the company's total market size. Use the FDC stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today FDC opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹635 and net income of ₹103, with EBITDA of ₹156, an operating margin of 18.0% and a profit margin of 16.2%.

FDC Market Cap ₹6,177.01 Cr.
FDC P/E Ratio (TTM) 19.30
FDC P/B Ratio 2.27
EPS (TTM) ₹17.29
Dividend Yield 1.34%
Debt to Equity 0.01
FDC 52 Week High ₹434.25
FDC 52 Week Low ₹321.10
Operating Margin 18.00%
Profit Margin 16.22%
FDC Revenue (TTM) ₹635.00
EBITDA ₹156.00
Net Income ₹103.00
Total Assets ₹2,919.00
Total Equity ₹2,485.00

FDC Share Price Chart

Track the current stock price of FDC with an interactive chart. Analyse FDC share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete FDC stock quote in one place.

The quote of ₹373.90 sits between the 52-week low of ₹321.10 and the 52-week high of ₹434.25, and the latest session moved -0.53% from the previous close.

FDC Company Profile - Fundamental Screener

Screen FDC company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for FDC shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE258B01022.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE258B01022

FDC Balance Sheet Screener

Screen FDC balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹2,919, up from ₹2,714 in 2025.

Latest statistics put total assets at ₹2,919 and shareholder funds at ₹2,485, with a leverage ratio of 0.01.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 2,919 2,714 2,468 2,343 2,270 1,956 1,813 1,640 1,505 1,468
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 999 852 680 699 705 689 674 682 674 678

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 70 71 60 50 42 18 19 16 18 18
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 2,485 2,281 2,097 1,981 1,956 1,734 1,547 1,445 1,276 1,270
Share Capital 16 16 16 17 17 17 17 18 18 18
Reserves & Surplus 2,469 2,265 2,081 1,966 1,940 1,717 1,530 1,428 1,259 1,252

FDC Income Statement Screener - Profit & Revenue Analysis

Screen FDC income statement and profit fundamentals. Analyze FDC quarterly results. FDC reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹635 and net profit was ₹103, equal to earnings per unit of ₹6.35, at an operating margin of 18%.

In that period expenses were ₹478, interest cost ₹2 and tax ₹37. The next period listed, 2026-Jun, shows revenue of ₹715 and net profit of ₹133.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec

Revenue and Expenses

Revenue 635 715 590 508 684 494 486 482 667 549 483 442 566 514 483
Expenses 478 525 508 438 508 439 433 406 492 444 418 386 414 410 374

Operating Costs and Margins

EBITDA 156 191 82 70 176 54 52 77 175 105 66 56 151 104 109
Operating Profit % 18.00% 21.00% 11.00% 11.00% 22.00% 7.00% 7.00% 12.00% 23.00% 14.00% 10.00% 11.00% 23.00% 16.00% 18.00%
Depreciation 14 15 16 16 15 15 15 10 11 14 13 10 10 10 10
Interest 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1

Profit and Earnings

Profit Before Tax 140 175 65 53 160 38 36 65 163 90 51 45 141 93 98
Tax 37 42 16 15 38 10 8 19 44 18 14 15 31 23 18
Net Profit 103 133 49 39 121 28 28 46 119 72 37 31 110 70 79
EPS 6.35 8.14 3.01 2.38 7.45 1.75 1.74 2.84 7.31 4.43 2.28 1.85 6.62 4.22 4.86

FDC Cash Flow Screener - Liquidity Fundamentals

Screen FDC cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹200, and net cash flow was an outflow of ₹3.

Over the same period, investing activities used ₹110 and financing activities used ₹93.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 200 318 221 155 162 207 250 112 150 155
Investing Activities -110 -199 -17 11 -145 -77 -98 -121 21 -144

Financing and Net Cash

Financing Activities -93 -92 -202 -180 -10 -129 -142 0 -169 0
Net Cash Flow -3 26 2 -14 7 1 10 -8 1 11

FDC Shareholding Pattern Screener

See FDC shareholding pattern with promoter, FII, and DII holdings. Check FDC promoter holding and ownership changes for FDC on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 69.66%, foreign institutions 2.40%, domestic institutions 6.29% and the public 16.82%, spread across 52,730 shareholders.

The shareholder count was 52,730 in 2026-Mar, compared with 55,045 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 69.66% 69.66% 69.66% 69.66% 69.66% 69.66% 69.66% 69.66%

Institutional Investors

FII Holding 2.40% 1.40% 1.58% 2.55% 2.41% 2.43% 2.32% 2.65%
DII Holding 6.29% 6.31% 6.59% 6.37% 7.17% 6.82% 6.27% 6.94%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 16.82% 17.64% 17.23% 16.22% 16.17% 16.40% 16.97% 16.54%
Other Holding 4.83% 4.99% 4.94% 5.20% 4.59% 4.70% 4.78% 4.22%
Shareholder Count 52,730 55,045 54,621 53,880 54,445 54,157 53,788 52,377

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by FDC. FDC dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹5.00 per unit for 2026-March, a yield of 1.34%, compared with ₹5.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹5.00, ₹5.00 and ₹0.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹5.00 1.34%
2025-March ₹5.00 1.56%
2024-March ₹0.00 0.00%
2023-March ₹0.00 0.00%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.80 0.28%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹2.25 0.90%

FDC Stock Index Membership - Nifty & Sensex

See which indices include FDC stock. Check FDC index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 9 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX BSE500, BSE INDEX MSL400.

Complete Index List

BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED

FDC Market Events Screener - Corporate Actions

Get FDC corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check FDC stock events that may affect FDC share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Buyback dated November 13, 2026, with a record date of November 13, 2026.

It is followed by Quarterly Result Announcement dated October 27, 2026 and Annual General Meeting dated September 24, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-13 2026-11-13 Buyback 500 0.00%
2026-10-27 2026-10-27 Quarterly Result Announcement NA 0.60%
2026-09-24 2026-09-24 Annual General Meeting NA 3.78%
2026-08-05 2026-08-05 Quarterly Result Announcement NA -1.78%
2026-05-27 2026-05-27 Quarterly Result Announcement NA 10.26%
2026-02-11 2026-02-11 Dividend ₹ 5.00 /share 2.66%
2026-02-05 2026-02-05 Quarterly Result Announcement NA 3.96%
2025-11-05 2025-11-05 Quarterly Result Announcement NA 3.59%
2025-09-25 2025-09-25 Annual General Meeting NA 4.36%
2025-08-07 2025-08-07 Quarterly Result Announcement NA -0.64%
2025-05-28 2025-05-28 Quarterly Result Announcement NA -1.68%
2025-02-12 2025-02-12 Quarterly Result Announcement NA -3.50%
2024-11-22 2024-11-22 Dividend ₹ 5.00 /share -10.27%
2024-11-06 2024-11-06 Quarterly Result Announcement NA 4.71%
2024-09-26 2024-09-26 Annual General Meeting NA -0.22%

FDC Competitors Screener - Peer Stocks Comparison

Screen FDC competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 448,076 41.10 61,674 12.69% 11,565 59.98
Divis Laboratories 294,139 90.70 11,067 13.95% 2,568 67.88
Torrent Pharmaceuticals 178,438 84.50 13,886 20.34% 2,138 49.31
Laurus Labs 119,949 98.10 6,868 22.01% 890 49.19
Zydus Life Science 118,902 27.60 27,658 17.64% 5,026 52.87
Dr Reddys Laboratories 115,011 41.70 35,059 3.90% 4,158 69.34
Cipla 112,656 39.40 29,045 2.24% 3,870 55.82
Mankind Pharma 108,490 48.40 14,636 14.85% 1,938 63.62
Aurobindo Pharma 103,223 26.40 34,145 5.56% 3,503 60.38
Lupin 90,393 17.30 29,039 26.75% 5,356 44.23

FDC Company Announcements - News & Reports Screener

Screen FDC latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated .

The next most recent announcements are dated and November 5, 2026.

Date Update Actions
Letter Of Offer - Buyback -
Letter of Offer -
2026-11-05 Disclosure under Regulation 30A of LODR -
2026-11-04 Disclosure Under Regulation 30A Of SEBI (Listing Obligation And Disclosure Requirements) Regulation 2015. -
2026-10-31 Disclosure under Regulation 30A of LODR -
2026-10-29 Public Announcement (Buyback) -
2026-10-29 Announcement under Regulation 30 (LODR)-Public Announcement-Buyback of Shares -
2026-10-28 Board Resolution For Buyback Of Fully Paid-Up Equity Shares Of The Company. -
2026-10-27 The Financial Results Of The Company For The Quarter And Half Year Ended September 30 2026. -
2026-10-27 Corporate Action- Record Date For Buyback. -
2026-10-27 Corporate Action-Buy back -
2026-10-27 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-10-27 Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. Tuesday October 27 2026 -
2026-10-21 Board Meeting Intimation for Notice Of Board Meeting Scheduled To Be Held On Tuesday October 27 2026. -
2026-10-07 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-28 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-25 Closure of Trading Window -
2026-09-24 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-18 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-17 Typographical Error In The Notice Of 86Th Annual General Meeting. -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹373.90, within a 52-week range of ₹321.10 to ₹434.25. The P/E ratio is 19.30 and the P/B ratio is 2.27, with earnings per unit of ₹17.29. Market capitalisation stands at ₹6,177.01 Cr and the dividend yield is 1.34%. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 20, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.